Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding OptiNose, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of OPTN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6865−3
Shares24.6M22.7M−1.90M (−7.7%)
Value$90.7M$70.5M−$20.2M (−22.2%)

New holders (13)

Institutions that held OptiNose, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to OPTN in Q2 2021
InstitutionSharesValue% of portfolio
Essex Investment Management Co LLC488,672$1.52M0.18%
Ergoteles LLC159,900$497.0K0.01%
Tibra Equities Europe Ltd102,300$318.0K0.10%
Alberta Investment Management Corp100,000$311.0K0.00%
HRT Financial LP97,056$301.0K0.00%
ExodusPoint Capital Management, LP45,940$143.0K0.00%
Susquehanna International Group, LLP38,032$118.0K0.00%
XTX Topco Ltd20,713$64.0K0.02%
Virtu Financial LLC17,689$55.0K0.01%
Clarity Financial LLC14,492$45.0K0.01%
Boothbay Fund Management, LLC11,365$35.0K0.00%
LMR Partners LLP10,465$33.0K0.00%
Optiver Holding B.V.8,788$27.0K0.00%

Sold out (16)

Institutions that held OptiNose, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.